Assessment of Mediastinal Involvement in Lung Cancer with Technetium-99m-Sestamibi SPECT

Journal of Nuclear Medicine

Volumn 37, Issue 6, 1996, Pages 938-942

  Chiti, Arturo ^a   Maffioli, Lorenzo S ^a   Infante, Maurizio ^a   Grasselli, Giacomo ^a   Incarbone, Matteo ^a   Gasparini, Massimo D ^a   Savelli, Giordano ^a   Bombardieri, Emilio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Lung cancer; Mediastinal lymph nodes; Technetium 99m sestamibi

Indexed keywords

DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

AGED; ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LUNG TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; MALE; MEDIASTINUM; MIDDLE AGED; RADIOGRAPHY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MEDIASTINUM; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030160533     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Wackers FJ, Berman DS, Maddahi J, et al Technetium-99m-hexakis-2-methoxyisobutylisonitrile: human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989;30:301-311.
2. West DJ, Najim YC, Mistry R, Clarke SE, Fogelman I, Maisey MN. The localization of myocardial ischaemia with technetium-99m-methoxyisobutylisonitrile and single photon emission computed tomography. Br J Radiol 1989;62:303-313.
3. Caner B, Kitapci M, Unlu M, et al. Technetium-99m-MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99m-MDP. J Nucl Med 1992;33:319-324.
4. Khalkhali I, Mena I, Jouanne E, Diggles L, Alle K, Klein S. Technetium-99m-sestamibi prone breast imaging in patients with suspicion of breast cancer [Abstract]. J Nucl Med 1993;34:140P.
5. Maffioli L, Gasparini M, Gramaglia A, et al. Detection of brain tumor recurrences with Tc-99m MIBI SPECT. J Nucl Biol Med 1994;38:255-256.
6. O'Driscoll CM, Baker F, Casey MJ, Duffey GJ. Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxyisobutylisonitrile scintigraphy: a case report. J Nucl Med 1991;32:2281-2283.
7. O'Tuama LM, Packard AB, Treves ST. SPECT imaging of pediatric brain tumor with hexakis (methoxyisobutylisonitrile)-technetium (I). J Nucl Med 1990;31:2040-2041.
8. Piwnica-Worms D, Holman BL. Non cardiac applications of hexakis-(alkylisonitrile) technetium-99m complexes [Editorial]. J Nucl Med 1990;31:1166-1167.
9. Scott AM, Kostakoglu L, O'Brien JP, Straus DJ, Abdel-Dajem HM, Larson SM. Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary thyroid lymphoma. J Nucl Med 1992;33:1396-1398.
10. Chili A, Maffioli L, Castellani M, Gasparini M, Capri G, Bombardieri E. Case report: lechnetium-99m-hexakis-2-methoxyisobutyl isonitrile imaging of breast cancer and myocardial infarction in the same patient. Tumori 1994;80:480-481.
11. 99mTc-sestamibi [Abstract]. J Nucl Med 1993;34(suppl):140P.
12. Abdel-Dayem HM, Scott A, Macapinlac H, Larson S. Tracer imaging in lung cancer. Eur J Nucl Med 1994;21:57-81.
13. 99mTc-hexakis 2-methoxyisobutylisonitrile in benign and malignant lesions in the lungs. Clin Nucl Med 1989;14:333-340.
14. 201Tl uptake in bronchial carcinoma [Abstract]. J Nucl Med 1989;30(suppl):845.
15. 99mTc-MIBI SPECT [Abstract]. J Nucl Med 1987:28(suppl):562.
16. Aktolun C, Bayhan H, Pabuccu Y, Bilgic H, Acar H, Koylu R. Assessment of tumor necrosis and detection of mediastinal lymph node metastasis in bronchial carcinoma with technetium-99m sestamibi imaging: comparison with CT scan. Eur J Nucl Med 1994:21:973-979.
17. Heller SL, Goodwin P. SPECT instrumentation: performance, lesion detection and recent innovations. Semin Nucl Med 1987;3:184-199.
18. Ginsberg RJ, Kris MG, Armstrong JG. Non-small-cell lung cancer. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology, 4th ed. Philadelphia: JB Lippincott; 1993:673-723.
19. Koch K, Broll I, Frank W, et al. Radiotherapy for lung cancer. In: Klapdor R, ed. Current tumor diagnosis: applications, clinical relevance, research, trends. Cancer of the lung - state and trends in diagnosis and therapy. Munich: Zuckschwerdt Verlag; 1994:898-902.
20. Shepherd FA, Ginsberg R, Patterson GA, et al. Surgical treatment for limited small-cell lung cancer: the University of Toronto Lung Oncology Group experience. Thorac Cardiovasc Surg 1991;101:385-393.
21. Libschitz HI, McKenna RJ. Mediastinal lymph node size in lung cancer. AJR Am J Roentgenol 1984;143:715-718.
22. Glazer G, Gross BH, Aisen AM, et al. Imaging of the pulmonary hilum: a prospective comparative study in patients with lung cancer. AJR Am J Roentgenol 1985;145:245-248.
23. Genereux GP, Howie JL. Normal mediastinal lymph node size and number. CT and anatomic study. AJR Am J Roentgenol 1984;142:1095-1100.
24. McCloud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992;182:319-323.
25. Webb WR, Gatsonis CA, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991;178:705-713.
26. Woch P, Soceck M, Daepp M, Kalendar WA. Lung: spiral volumetric CT with single-breath-hold technique. Radiology 1990;176:864-867.
27. Rubin E, Sanders C, Harvey JC, Beattie EJ. Diagnostic imaging and staging of primary lung cancer. Semin Surg Oncol 1993;9:85-91.
28. Heelan RT, Demas BE, Caravelli JF, et al. Superior sulcus tumors: CT and MRI imaging. Radiology 1989;170:637-641.
29. Laurent F, Drouillard J, Dorcier F, et al. Bronchogenic carcinoma staging: CT vs MR imaging. Assessment with surgery. Eur J Cardiothorac Surg 1988;2:31-36.
30. Padovani B, Mouroux J, Seksik L, et al. Chest wall invasion by bronchogenic carcinoma: evaluation with MR imaging. Radiology 1993;187:33-38.
31. Kayser K, Buzelbruk H, Probst G, et al. Retrospective and prospective tumor staging evaluating prognostic factors in operated bronchus carcinoma patients. Cancer 1987;59:355-361.
32. White CS, Templeton PA, Belani CP. Imaging in lung cancer. Semin Oncol 1993;20:142-152.
33. Laissy JP, Gay-Depassier P, Soyer P, et al. Enlarged mediastinal lymph nodes in bronchogenic carcinoma: assessment in dynamic-contrast enhanced MR imaging. Work in progress. Radiology 1994;191:263-267.
34. Alazraki NP, Ramsdell JW, Taylor A, Friedman PJ, Peters RM, Tisi GM. Reliability of gallium scan, chest radiography compared to mediastinoscopy for evaluating mediastinal spread in lung cancer. Am Rev Respir Dis 1978;117:415-420.
35. De Meester TR, Golomb HM, Kirchner P, et al. The role of Ga-67 scanning in the clinical staging and preoperative evaluation of patients with carcinoma of the lung. Ann Thorac Surg 1979;18:451-459.
36. Neumann R, Merino M, Hoffer PB. Ga-67 in hilar and mediastinal staging of primary lung carcinomas [Abstract]. J Nucl Med 1980;21(suppl):32.
37. Bandt J, Verzijlbergen JF, Duurkens VAM, Pauwels EKJ. Thallium-201 mediastinal SPECT is able to accurately select patients who need mediastinoscopy in the staging of bronchial carcinoma [Abstract]. Eur J Nucl Med 1994;21:799.
38. 131l-anti-CEA and anti-CA19.9 immunoscintigraphy versus computed tomography. Lung Cancer Ireland 1994;11:209-219.
39. Dosio F, Magnani P, Paganelli G, Samuel A, Chiesa G, Fazio F. Three step tumor pre-targeting in lung cancer immunoscintigraphy. J Nucl Biol Med 1993;37:228-232.
40. Maini CL, Tofani A, Venturo I, et al. Somatostatin receptor imaging in small-cell lung cancer using indium-111-DTPA-octreotide: a preliminary study. Nucl Med Commun 1993;14:962-968.
41. O'Byrne KJ, Ennis JT, Freyne PJ, et al. Scintigraphic imaging of small-cell lung cancer with [indium-111]pentetreotide, a radiolabeled somatostatin analog. Br J Cancer 1994;69:762-766.
42. 111In-DTPA octreotide scintigraphy. Eur J Cancer 1995;31A:184-188.
43. Kwekkeboom DJ, Kho GS, Lamberts SWJ, Reubi JC, Laissue JA, Krenning EP. The value of octreotide scintigraphy in patients with lung cancer. Eur J Nucl Med 1994;21:1106-1113.
44. Piwnica-Worms D, Chiu ML, Croop JM, Kronauge JF. Enhancement of Tc-99m sestamibi accumulation in multidrug resistance (MDR) cells by cytotoxic drugs and MDR reversing agents [Abstract]. J Nucl Med 1994;34(suppl):1l40P.